Elisa to upgrade its Network with Alcatel-Lucent’s Equipment; Zalicus Merging with Epirus Biopharmaceuticals

Follow this company

Companies Mentioned

04/17/2014 [ACCESSWIRE]

Alcatel-Lucent (NYSE: ALU) – For an in-depth report on Alcatel-Lucent follow: www.BullTrends.com/stockquote/ALU 

Shares of ALU closed up 3.35% on about 22 million shares traded. The stock was one of the most active stocks on the NYSE. The company announced that Finnish wireless carrier and ISP Elisa will upgrade its network with the company's wireless network equipment. Both companies said they will deploy the "industry's most advanced end-to-end IP/MPLS network solution" as part of the network upgrade. The upgrade will help improve both in-home Internet connections and wireless connectivity.

Zalicus Inc. (NASDAQ: ZLCS) – For an in-depth report on Zalicus Inc. follow: www.BullTrends.com/stockquote/ZLCS 

Shares of Zalicus Inc. closed up 31.07% with 13.6 million shares traded on Wednesday. The company will merge with Epirus Biopharmaceuticals in an all-stock transaction. Zalicus will be known as Epirus and will operate under the latter company's management team led by Amit Munshi as president and CEO. Current Zalicus stockholders will own approximately 19% of the company. The merger will create a publicly-traded company listed on the NASDAQ.

Cannabis-Rx Inc. (OTC: CANA) – For an in-depth report on Cannabis-Rx Inc. follow: www.BullTrends.com/stockquote/CANA 

Shares of Cannabis-Rx closed down about 42% on nearly 5.5 million shares traded. The stock was one of the biggest decliners in the OTC marketplace. The company announced the appointment of Munjit S. Johal as Treasurer and Chief Financial Officer. Mr. Johal will play an integral role in advancing the Company’s long-term growth strategy and overseeing its capital structure and regulatory requirements.

Intel Corporation (NASDAQ: INTC) – For an in-depth report on Intel Corporation follow: www.BullTrends.com/stockquote/INTC                  

Shares of INTC closed up a modest 0.60% on about 59 million shares traded on Wednesday. The stock even hit a new yearly high of $27.24 during intra-day trading. The company posted in-line Q2 results and received a buy-to-neutral downgrade from B. Riley & Co. The firm also gave the stock a $29 price target.


Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures. 


Leave a comment...

Your Name